Embattled biotech appoints new president, 7 months after former CEO ousted


The new leader will have his work cut out for him in leading the embattled company.

Previous CapStar CEO: 'Never say never' but new markets aren't the bank's focus
Next Martin Shkreli's onetime company loses 80% of value as Covid drug trial fails